Has the Rate of CD4 Cell Count Decline before Initiation of Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic among MSM?

L Gras, RB Geskus, S Jurriaans, Michael den Bakker, A van Sighem, D Bezemer, C Fraser, JM Prins, B Berkhout, F de Wolf

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)
11 Downloads (Pure)

Abstract

Introduction: Studies suggest that the HIV-1 epidemic in the Netherlands may have become more virulent, leading to faster disease progression if untreated. Analysis of CD4 cell count decline before antiretroviral therapy (ART) initiation, a surrogate marker for disease progression, may be hampered by informative censoring as ART initiation is more likely with a steeper CD4 cell count decline. Methods: Development of CD4 cell count from 9 to 48 months after seroconversion was analyzed using a mixed-effects model and 2 models that jointly modeled CD4 cell counts and time to censoring event (start ART, <100 CD4 cells/mm(3), or AIDS) among therapy-naive MSM HIV-1 seroconverters in the Netherlands. These models make different assumptions about the censoring process. Results: All 3 models estimated lower median CD4 cell counts 9 months after seroconversion in later calendar years (623, 582, and 541 cells/mm(3) for 1984-1995 [n = 111], 1996-2002 [n = 139], and 2003-2007 seroconverters [n = 356], respectively, shared-parameter model). Only the 2 joint-models found a trend for a steeper decline of CD4 cell counts with seroconversion in later calendar years (overall p-values 0.002 and 0.06 for the pattern-mixture and the shared-parameter model, respectively). In Conclusion: Mixed-effects models underestimate the CD4 cell decline prior to starting ART. Joint-models suggest that CD4 cell count declines more rapidly in patients infected between 2003 and 2007 compared to patients infected before 1996.
Original languageUndefined/Unknown
JournalPLoS One (print)
Volume8
Issue number5
DOIs
Publication statusPublished - 2013

Research programs

  • EMC MM-04-27-01
  • EMC MM-04-28-04

Cite this